Chemotherapy authorisation with Adeslas: protocol, day hospital and 30 days
The 30-day rule applied to chemotherapy
Adeslas publishes a general rule whereby most authorisations expire 30 calendar days from the date indicated in the request. In chemotherapy, a typical six-cycle protocol delivered every twenty-one or twenty-eight days does not fit inside a single authorisation with that window. Each cycle needs its own coordination with the 30-day rule, and the day hospital lead has to watch expiries in parallel with clinical scheduling.
Usual oncology documentation
The Adeslas chemotherapy request shares the same operational structure as with other insurers: oncology report justifying the regimen, ICD-10-ES diagnosis, day hospital procedure, prescribing oncologist with identifier number and, where the regimen requires, specific validation of the specialty drug. Whether an Adeslas portal with full access for the clinic to submit cycles on the patient behalf exists is not confirmed publicly and depends on the centre agreement.
Where revenue leaks in Adeslas oncology
In Adeslas oncology, leakage does not appear as initial denial but as a cycle delivered outside valid authorisation. The previous cycle ends, the next one is scheduled three weeks later, the 30-day rule no longer applies to the new date and nobody requests the next-cycle authorisation until the patient is already in the day hospital chair. Per-cycle cost is high and annual cost across several patients on protocol can reach tens of thousands of euros.
How SaludComply approaches it
SaludComply tracks each chemotherapy cycle as a live authorisation tied to the protocol. The queue alerts when the next-cycle planned date approaches and the current authorisation is out of window, prepares the request with equivalent clinical documentation and leaves the submission to the oncology coordinator approval. The centre stops relying on personal memory for a decision that directly hits monthly revenue.
Verified sources
- Adeslas — Autorizaciones — fuente oficial sobre proceso y caducidad
- SaludComply — diagnóstico de autorizaciones — diagnóstico de fuga por autorizaciones
Related pages
Calculate revenue lost to authorisations
Use the SaludComply authorisation diagnostic to estimate monthly loss, recoverable range and operational complexity. No patient data required.